Type : Carbamate,Trimethylammonium
Chemical_Nomenclature : N-p-chlorophenyl-N-methylcarbamate of m-hydroxyphenyltrimethylammonium bromide
Canonical SMILES : C1=C(C=CC=C1OC(N(C)C2=CC=C(C=C2)Cl)=O)[N+](C)(C)C.[Br-]
InChI : InChI=1S\/C17H20ClN2O2.BrH\/c1-19(14-10-8-13(18)9-11-14)17(21)22-16-7-5-6-15(12-16)20(2,3)4\;\/h5-12H,1-4H3\;1H\/q+1\;\/p-1
InChIKey : PCQGALCVXJWHNH-UHFFFAOYSA-M
Other name(s) :
Families : Nu-1250 ligand of proteins in family
ACHE
Title : [Anticholinesteratic and pharmacological effects of the bromide of N-P-Chlorophenyl-methylcarbamate of M-Hydroxyphenyltrimethylammonium (NU 1250)] - |
Author(s) : Casier H , De Vleeschhouwer GR |
Ref : Archives Internationales de Pharmacodynamie et de Therapie , 90 :412 , 1952 |
PubMedID: 12986938 |
Title : Tubocurarine antagonism and inhibition of cholinesterases - |
Author(s) : Blaschko H , Bulbring E , Chou TC |
Ref : British Journal of Pharmacology , 4 :29 , 1949 |
PubMedID: 18113150 |
Array ( [id] => 4995 [inhibitor] => Nu-1250 [type] => Array ( [0] => Carbamate [1] => Trimethylammonium ) [other_name] => Array ( ) [chemical_nomenclature] => N-p-chlorophenyl-N-methylcarbamate of m-hydroxyphenyltrimethylammonium bromide [formula] => C17H20N2O2ClBr [cas_number] => [mw] => 399,71 [pick_me_to_call] => display_script [kinetic_parameter] => [paper] => Blaschko_1949_Br.J.Pharmacol_4_29 || Burn_1954_J.Physiol_124_489 || Casier_1952_Arch.Int.Pharmacodyn.Ther_90_412 [comment] => [gene_locus] => [kin_inhibitor] => [cid] => [family] => ACHE [inchikey] => PCQGALCVXJWHNH-UHFFFAOYSA-M [canonicalsmiles] => C1=C(C=CC=C1OC(N(C)C2=CC=C(C=C2)Cl)=O)[N+](C)(C)C.[Br-] [inchi] => InChI=1S\/C17H20ClN2O2.BrH\/c1-19(14-10-8-13(18)9-11-14)17(21)22-16-7-5-6-15(12-16)20(2,3)4\;\/h5-12H,1-4H3\;1H\/q+1\;\/p-1 [wikipedia] => [iupharlig] => [structure] => [substrate] => [interact_gene_locus] => [mutation] => [comment2] => [extoxnet] => [news] => [theoretical_model] => )